Severe haemolytic anaemia with erythrophagocytosis following the bite of a brown recluse spider
Bilateral renal infiltration as the initial presentation of multiple myeloma
Current regimens and novel agents for mantle cell lymphoma
Targeting PI3-kinase (PI3K), AKT and mTOR axis in lymphoma
Managing children with chronic myeloid leukaemia (CML) : Recommendations for the management of CML in children and young people up to the age of 18 years
A transgenic zebrafish model expressing KIT -D816V recapitulates features of aggressive systemic mastocytosis
Platelet count doubling after the first cycle of azacitidine therapy predicts eventual response and survival in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukaemia but does not add to prognostic utility of the revised IPSS
PIM and AKT kinase inhibitors show synergistic cytotoxicity in acute myeloid leukaemia that is associated with convergence on mTOR and MCL1 pathways
Acute myeloid leukaemia with myelodysplastic features in children: a report of Japanese Paediatric Leukaemia/Lymphoma Study Group
Wnt inhibition leads to improved chemosensitivity in paediatric acute lymphoblastic leukaemia
High flow cytometric scores identify adverse prognostic subgroups within the revised international prognostic scoring system for myelodysplastic syndromes
A novel canine model of immune thrombocytopenia: has immune thrombocytopenia (ITP) gone to the dogs?
Hepatocellular carcinoma in thalassaemia: an update of the Italian Registry
Lenalidomide desensitization for delayed hypersensitivity reactions in 5 patients with multiple myeloma
Updates to the guidelines for the diagnosis and management of multiple myeloma
Defining the best cut-off value for lymphopenia in diffuse large B cell lymphoma treated with immuno-chemotherapy
Complications of HbH disease in adulthood
First line treatment of chronic phase chronic myeloid leukaemia patients with the generic formulations of imatinib mesylate
Pilot study of sorafenib in relapsed or refractory peripheral and cutaneous T-cell lymphoma
Development of extramedullary sites of leukaemia during ruxolitinib therapy for myelofibrosis